Pure Global

REALY TECH Creatine Kinase MB (CK-MB) Assay Reagent Kit (CMIA) - Indonesia BPOM Medical Device Registration

REALY TECH Creatine Kinase MB (CK-MB) Assay Reagent Kit (CMIA) is a medical device registered with Indonesia's BPOM (Badan Pengawas Obat dan Makanan) under Analysis ID AKL 20101324548. The device is manufactured by HANGZHOU REALY TECH CO., LTD. from China, and is classified as Risk Class Kelas Resiko : B. The authorized representative in Indonesia is PT. NUSANTARA BINA DIAGNOSTIKA.

This page provides comprehensive regulatory information including complete registration details, manufacturer information, authorized representative details, product classification, and related products. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
BPOM Registered
Risk Class Kelas Resiko : B
REALY TECH Creatine Kinase MB (CK-MB) Assay Reagent Kit (CMIA)
Analysis ID: AKL 20101324548

Risk Classification

Kelas Resiko : B

Product Class

Kelas : 2

Country of Origin

China

Authorized Representative

PT. NUSANTARA BINA DIAGNOSTIKA

AR Address

Pertokoan Bali View No. 35 Jl. Rajawali Pisangan Ciputat, Tangerang Selatan

Registration Date

Mar 05, 2024

Expiry Date

Aug 30, 2026

Product Type

Clinical Chemistry Test System

Creatine phosphokinase/creatine kinase or isoenzymes test system(kit & cair)

Invitro Diagnostics

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing